Danielle C. Hamm

Danielle C. Hamm

Auto-generated profile, based on publicly available information

Danielle C. Hamm

Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ELElizabeth D. Larson
Elizabeth D. Larson
HKHideyuki Komori
Hideyuki Komori
TGTyler J. Gibson
Tyler J. Gibson
COCyrina M. Ostgaard
Cyrina M. Ostgaard
DHDanielle C. Hamm
Danielle C. Hamm
MHMelissa M. Harrison
Melissa M. Harrison
During Drosophila embryogenesis, the essential pioneer factor Zelda defines hundreds of cis-regulatory regions and in doing so reprograms the zygotic transcriptome. While Zelda is essential later in development, it is unclear how the ability of Zelda to define cis-regulatory regions is shaped by cell-type-specific chromatin architecture. Asymmetric division of neural stem cells (neuroblasts) in the fly brain provide an excellent paradigm for investigating the cell-type-specific functions of this pioneer factor. We show that Zelda synergistically functions with Notch to maintain neuroblasts in an undifferentiated state. Zelda misexpression reprograms progenitor cells to neuroblasts, but this capacity is limited by transcriptional repressors critical for progenitor commitment. Zelda genomic occupancy in neuroblasts is reorganized as compared to the embryo, and this reorganization is correlated with differences in chromatin accessibility and cofactor availability. We propose that Zelda regulates essential transitions in the neuroblasts and embryo through a shared gene-regulatory network driven by cell-type-specific enhancers.

25 September 2023 in PLOS Biology
Verified
Journal Article
Open access
PDF file
DHDanielle C. Hamm
Danielle C. Hamm
EPEllen M. Paatela
Ellen M. Paatela
SBSean R. Bennett
Sean R. Bennett
CWChao-Jen Wong
Chao-Jen Wong
ACAmy E. Campbell
Amy E. Campbell
STStephen J. Tapscott
Stephen J. Tapscott
Translational control is critical for cell fate transitions during development, lineage specification, and tumorigenesis. Here, we show that the transcription factor double homeobox protein 4 (DUX4), and its previously characterized transcriptional program, broadly regulates translation to change the cellular proteome. DUX4 is a key regulator of zygotic genome activation in human embryos, whereas misexpression of DUX4 causes facioscapulohumeral muscular dystrophy (FSHD) and is associated with MHC-I suppression and immune evasion in cancer. We report that translation initiation and elongation factors are disrupted downstream of DUX4 expression in human myoblasts. Genome-wide translation profiling identified mRNAs susceptible to DUX4-induced translation inhibition, including those encoding antigen presentation factors and muscle lineage proteins, while DUX4-induced mRNAs were robustly translated. Endogenous expression of DUX4 in human FSHD myotubes and cancer cell lines also correlated with reduced protein synthesis and MHC-I presentation. Our findings reveal that DUX4 orchestrates cell state conversion by suppressing the cellular proteome while maintaining translation of DUX4-induced mRNAs to promote an early developmental program.

15 April 2026 in Genes & Development
Verified
Journal Article
Open access
PDF file
DHDanielle C. Hamm
Danielle C. Hamm
AOAidan B. O'DOnnell
Aidan B. O'DOnnell
SBSean R. Bennett
Sean R. Bennett
RLRichard J.L.F. Lemmers
Richard J.L.F. Lemmers
PVPatrick J. van der Vliet
Patrick J. van der Vliet
STStephen J. Tapscott
Stephen J. Tapscott
DUX4 initiates the first wave of zygotic genome activation (ZGA) in the human embryo, and its misexpression in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). However, other factors that help regulate ZGA-like transcription in human development and disease are still not fully understood. Here we identify Krüppel-like factor 18 (KLF18) as a component of a DUX4 feed-forward network that is necessary for expression of KLF17 and a subset of DUX4-regulated totipotency-associated genes. We mapped the genome-wide binding profile of KLF18 downstream from DUX4 and showed that its activity is influenced by DUX4 and chromatin accessibility. We found that in contrast to the rodent ortholog, human KLF18 has a predicted β-solenoid structure composed of a variable number of tandem repeats (VNTR) with multiple different structural variants in the human population. Expression of different KLF18 variants in combination with DUX4 showed similar transcriptional activity, whereas assessment of KLF18 structural variants in individuals with FSHD1 showed inconsistent association with disease severity that requires further study as a modifier locus. Together, these findings establish the polymorphic transcription factor KLF18 as a critical component of a DUX4-initiated feed-forward network and a candidate locus for human diversity.